All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Performance comparison

Follistatin 344 vs Tesamorelin

An educational, source-based comparison of Follistatin 344 and Tesamorelin — how each peptide works, what it's researched for, and what to know before going deeper.

Muscle · Myostatin Inhibition
Follistatin 344

Myostatin-binding protein fragment researched for muscle growth.

Mechanism

A naturally occurring glycoprotein that binds and neutralizes myostatin and activin, releasing the natural brake on skeletal muscle growth in preclinical models.

Research areas
  • Muscular dystrophy models
  • Skeletal muscle hypertrophy
  • Age-related sarcopenia (preclinical)
Considerations
  • Off-target effects on activin signaling (reproductive, cardiac) are a concern.
  • Not FDA-approved; banned by WADA.
Full Follistatin 344 profile →
Growth Hormone Axis
Tesamorelin

GHRH analog FDA-approved for HIV-associated visceral fat.

Mechanism

A stabilized analog of growth hormone-releasing hormone (GHRH) that stimulates pulsatile endogenous GH and IGF-1 release. FDA-approved (Egrifta) for the reduction of excess abdominal visceral fat in HIV-infected patients with lipodystrophy.

Research areas
  • Visceral adipose tissue reduction (approved)
  • Cognitive function in older adults (research)
  • NAFLD / hepatic fat (research)
Considerations
  • FDA-approved only for HIV-associated lipodystrophy.
  • May affect glucose tolerance; monitor in at-risk patients.
  • Requires physician oversight.
Full Tesamorelin profile →

Follistatin 344 vs Tesamorelin — Key differences

  • Class: Follistatin 344 is classified as Muscle · Myostatin Inhibition, while Tesamorelin is Growth Hormone Axis.
  • Primary research focus: Follistatin 344muscular dystrophy models; Tesamorelinvisceral adipose tissue reduction (approved).
  • Tag: Muscle vs Body composition.

Related comparisons